<DOC>
	<DOCNO>NCT01359670</DOCNO>
	<brief_summary>This study , support Parent Project Muscular Dystrophy , determine tadalafil sildenafil improve muscle blood flow exercise boys Duchenne muscular dystrophy .</brief_summary>
	<brief_title>Tadalafil Sildenafil Duchenne Muscular Dystrophy</brief_title>
	<detailed_description>Duchenne muscular dystrophy ( DMD ) rare , progressive fatal muscle disease affect boys account 80 % muscular dystrophy case . Tadalafil sildenafil medication approve FDA treatment erectile dysfunction pulmonary hypertension . This class medication improve muscle blood flow mouse model muscular dystrophy , benefit boy DMD unknown . The purpose study 1 ) determine tadalafil sildenafil improve muscle blood flow exercise boys DMD ; 2 ) inform design subsequent , randomize , multi-center trial clinical endpoint . The investigator enroll boy DMD age 7 15 year ambulatory without clinical heart failure . Participants undergo 6 visit course 5 week . The initial visit include medical history , physical exam , echocardiogram , blood draw determine eligibility study . Boys give Holter monitor ( heart monitor ) wear 48 hour observe irregular heartbeat abnormality . Eligible boy randomize one two study drug : tadalafil sildenafil . The boy take low dose ( 0.25mg/kg ) study drug first 2 day intermediate dose ( 0.5mg/kg ) subsequent 5 day . Then , boy take high dose ( 1.0mg/kg ) study drug 1 week . Tadalafil take daily sildenafil take four time daily . Study visit occur 2 time baseline , 2 time medication , 1 time washout medication . For visit , boy undergo arm blood flow hand grip exercise protocol . In procedure , blood flow oxygen delivery forearm muscle measure ( noninvasively ) application lower body negative pressure rest handgrip exercise . Lower body negative pressure stimulate blood flow change normally occur person sits lie . During visit , boys complete quality life questionnaire , echocardiogram , 6-minute walk test . At home , boys wear accelerometer measure physical activity Holter monitor check irregular heartbeat . For boys wish continue study , option cross-over complete study visit drug originally receive .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>1 . Diagnosis DMD confirm muscle biopsy DNA analysis 2 . Age 715y 3 . Ambulatory 4 . No clinical evidence heart failure 1 . Hypertension , diabetes , heart failure standard clinical criterion 2 . Elevated BNP level ( &gt; 100 pg/ml ) 3 . LVEF &lt; 50 % 4 . Wheelchair bind 5 . Cardiac rhythm disorder , specifically : rhythm sinus , SVT , atrial fibrillation , ventricular tachycardia 6 . Continuous ventilatory support 7 . Liver disease 8 . Renal impairment 9 . Contraindications tadalafil sildenafil ( use nitrate , alphablockers , CYP3A inhibitor , amlodipine , PDE5A inhibitor )</criteria>
	<gender>Male</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Duchenne</keyword>
	<keyword>muscular dystrophy</keyword>
	<keyword>tadalafil</keyword>
	<keyword>sildenafil</keyword>
	<keyword>muscle ischemia</keyword>
	<keyword>exercise</keyword>
</DOC>